financetom
Business
financetom
/
Business
/
VIAVI Accelerates Innovation with Spirent Acquisition, Targeting $75M in Synergies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VIAVI Accelerates Innovation with Spirent Acquisition, Targeting $75M in Synergies
Mar 5, 2024 3:28 AM

VIAVI Solutions ( VIAV ) penned a deal to acquire Spirent Communications ( SPNUF ) (OTC:SPMYY) for approximately £1.0 billion ($1.3 billion) in a cash offer.

The acquisition price values Spirent based on the British pound sterling to U.S. dollar exchange rate on March 4, 2024.

Spirent offers products, services and managed solutions that address technologies’ test, assurance and automation challenges, including 5G, software-defined wide area networks (SD-WAN), cloud and autonomous vehicles. 

As per the terms, Spirent shareholders will receive 172.5 pence per share in cash along with a special dividend per share of 2.5 pence in place of a final dividend for the year ended December 31, 2023. Spirent Board intends to unanimously recommend this all-cash offer.

The company plans to fund the buyout with its existing cash, a fully committed $800 million 7-year term loan, and a $400 million investment from Silver Lake in the form of a fully committed senior convertible note.

In connection with the Silver Lake investment, Ken Hao, Chairman and a Managing Partner of Silver Lake, will join the VIAVI board.

The acquisition is expected to close in the second half of 2024, subject to shareholder approvals and other customary closing conditions.

Oleg Khaykin, President and CEO of VIAVI, said, “Combining our leading communications test and measurement and optical technologies and Spirent’s high-performance testing and assurance solutions is expected to deliver enhanced product solutions and applications, accelerate growth in new markets and strengthen innovation through expanded engineering and design capabilities.”

Synergies: VIAVI projects operational efficiencies to result in annual run-rate cost synergies of up to $75 million approximately two years after the deal’s completion.

Also, the company expects to utilize its U.S. net operating losses to lower the combined group’s blended non-GAAP tax rate and plans to prioritize debt paydown using free cash flow generation to reduce leverage ratios towards 4.0x gross and 3.0x net over the long term.

As of December 30, 2023, the company held $571.8 million in total cash, short-term investments, and short-term restricted cash.

Price Action: VIAV shares closed at $9.73 on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved